Endocrinology Medical News about Thyrotropin-Stimulating Hormone Receptor

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Thyrotropin-Stimulating Hormone Receptor Gene Analysis in Pediatric Patients with Non Autoimmune Subclinical Hypothyroidism
Journal of Clinical Endocrinology and Metabolism, 10/15/09

Nicoletti A et al. – To date, this study demonstrates the highest prevalence (29%) of TSHR gene mutations in children and adolescents with nonautoimmune subclinical hypothyroidism not selected by neonatal screening. Functional studies show that some mutations cause a slight inactivation of the TSHR. This reveals a possible limit of the in vitro study or of the knowledge of mechanisms involving TSHR, or that other candidate genes must be considered.

<< Previous
Pioglitazone Treatment Enlarges Subcutaneous Adipocytes in...

Next >>
Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The...

D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer
Annals of Oncology, 11/04/09 Relevance Score: 68%

The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors
The Breast, 10/21/09 Relevance Score: 68%

Activational effects of sex hormones on cognition in men
Clinical Endocrinology, 10/16/09 Relevance Score: 68%

Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III tandem study
Journal of Clinical Oncology, 10/01/09 Relevance Score: 68%

Luteinizing hormone-releasing hormone agonists in the treatment of breast cancer
Expert Opinion in Pharmacotherapy, 10/19/09 Relevance Score: 67%